Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF and Rituximab - Contacts and Locations

Home

Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF and Rituximab

This study is currently recruiting participants.

Study NCT00208975. Last updated on June 24, 2008. Information provided by Emory University

Please refer to this study by its ClinicalTrials.gov identifier: NCT00208975

Contacts


Contact: Christopher Flowers, MD	888-946-7447

Locations


United States, Georgia
	Emory University Winship Cancer Institute	Recruiting
	Atlanta, Georgia, United States, 30322
	Principal Investigator: Christopher Flowers, MD

Sponsors and Collaborators

Emory University

Bayer

Investigators


Principal Investigator:	Christopher Flowers, MD	Emory University Winship Cancer Institute